Clinical Utility of Single-Beat E/e′ Obtained by Simultaneous Recording of Flow and Tissue Doppler Velocities in Atrial Fibrillation With Preserved Systolic Function

JACC: Cardiovascular Imaging

Volumn 2, Issue 10, 2009, Pages 1147-1156

  Kusunose, Kenya ^a   Yamada, Hirotsugu ^a   Nishio, Susumu ^a   Tomita, Noriko ^a   Niki, Toshiyuki ^a   Yamaguchi, Koji ^a   Koshiba, Kunihiko ^a   Yagi, Shusuke ^a   Taketani, Yoshio ^a   Iwase, Takashi ^a   Soeki, Takeshi ^a   Wakatsuki, Tetsuzo ^a   Akaike, Masashi ^a   Sata, Masataka ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

atrial fibrillation; diastolic function; Doppler echocardiography

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ADULT; AGED; ARTERY CATHETERIZATION; ARTICLE; CALCULATION; CHRONIC DISEASE; DIASTOLE; DOPPLER ECHOCARDIOGRAPHY; FEMALE; FLOW RATE; HEART ATRIUM FIBRILLATION; HEART HEMODYNAMICS; HEART LEFT VENTRICLE; HUMAN; LUNG ARTERY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PULMONARY ARTERY OCCLUSION PRESSURE; RR INTERVAL; SENSITIVITY AND SPECIFICITY; SYSTOLE; TISSUE DOPPLER IMAGING;

ADULT; AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; BIOLOGICAL MARKERS; CATHETERIZATION, SWAN-GANZ; CORONARY CIRCULATION; DIASTOLE; ECHOCARDIOGRAPHY, DOPPLER, COLOR; ECHOCARDIOGRAPHY, DOPPLER, PULSED; FEMALE; HEART RATE; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; MITRAL VALVE; NATRIURETIC PEPTIDE, BRAIN; PREDICTIVE VALUE OF TESTS; PULMONARY WEDGE PRESSURE; SENSITIVITY AND SPECIFICITY; SYSTOLE; VENTRICULAR FUNCTION, LEFT;

EID: 70349773243     PISSN: 1936878X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcmg.2009.05.013     Document Type: Article

References (30)

1. Gersh B.J., Tsang T.S., and Seward J.B. The changing epidemiology and natural history of nonvalvular atrial fibrillation: clinical implications. Trans Am Clin Climatol Assoc 115 (2004) 149-160
2. Lloyd-Jones D.M., Wang T.J., Leip E.P., et al. Lifetime risk for development of atrial fibrillation: the Framingham Heart Study. Circulation 110 (2004) 1042-1046
3. Zile M.R., Baicu C.F., and Gaasch W.H. Diastolic heart failure-abnormalities in active relaxation and passive stiffness of the left ventricle. N Engl J Med 350 (2004) 1953-1959
4. Zile M.R., and Lewinter M.M. Left ventricular end-diastolic volume is normal in patients with heart failure and a normal ejection fraction: a renewed consensus in diastolic heart failure. J Am Coll Cardiol 49 (2007) 982-985
5. Yamanaka-Funabiki K., Onishi K., Tanabe M., et al. Single beat determination of regional myocardial strain measurements in patients with atrial fibrillation. J Am Soc Echocardiogr 19 (2006) 1332-1337
6. Al-Omari M.A., Finstuen J., Appleton C.P., Barnes M.E., and Tsang T.S. Echocardiographic assessment of left ventricular diastolic function and filling pressure in atrial fibrillation. Am J Cardiol 101 (2008) 1759-1765
7. Nakamura Y., Konishi T., Nonogi H., Sakurai T., Sasayama S., and Kawai C. Myocardial relaxation in atrial fibrillation. J Am Coll Cardiol 7 (1986) 68-73
8. Nagueh S.F., Mikati I., Kopelen H.A., Middleton K.J., Quinones M.A., and Zoghbi W.A. Doppler estimation of left ventricular filling pressure in sinus tachycardia. A new application of tissue Doppler imaging. Circulation 98 (1998) 1644-1650
9. Ommen S.R., Nishimura R.A., Appleton C.P., et al. Clinical utility of Doppler echocardiography and tissue Doppler imaging in the estimation of left ventricular filling pressures: a comparative simultaneous Doppler-catheterization study. Circulation 102 (2000) 1788-1794
10. Okura H., Takada Y., Kubo T., et al. Tissue Doppler-derived index of left ventricular filling pressure, E/E', predicts survival of patients with non-valvular atrial fibrillation. Heart 92 (2006) 1248-1252
11. Sohn D.W., Song J.M., Zo J.H., et al. Mitral annulus velocity in the evaluation of left ventricular diastolic function in atrial fibrillation. J Am Soc Echocardiogr 12 (1999) 927-931
12. Wei C.M., Heublein D.M., Perrella M.A., et al. Natriuretic peptide system in human heart failure. Circulation 88 (1993) 1004-1009
13. Yoshimura M., Yasue H., Tanaka H., et al. Responses of plasma concentrations of A type natriuretic peptide and B type natriuretic peptide to alacepril, an angiotensin-converting enzyme inhibitor, in patients with congestive heart failure. Br Heart J 72 (1994) 528-533
14. Matsumoto A., Hirata Y., Momomura S., et al. Effects of exercise on plasma level of brain natriuretic peptide in congestive heart failure with and without left ventricular dysfunction. Am Heart J 129 (1995) 139-145
15. Maeda K., Tsutamoto T., Wada A., Hisanaga T., and Kinoshita M. Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction. Am Heart J 135 (1998) 825-832
16. Berger R., Huelsman M., Strecker K., et al. B-type natriuretic peptide predicts sudden death in patients with chronic heart failure. Circulation 105 (2002) 2392-2397
17. Harrison A., Morrison L.K., Krishnaswamy P., et al. B-type natriuretic peptide predicts future cardiac events in patients presenting to the emergency department with dyspnea. Ann Emerg Med 39 (2002) 131-138
18. Koitabashi T., Inomata T., Niwano S., et al. Distinguishable optimal levels of plasma B-type natriuretic peptide in heart failure management based on complicated atrial fibrillation. Int Heart J 46 (2005) 453-464
19. Rienstra M., Van Gelder I.C., Van den Berg M.P., Boomsma F., and Van Veldhuisen D.J. Natriuretic peptides in patients with atrial fibrillation and advanced chronic heart failure: determinants and prognostic value of (NT-)ANP and (NT-pro)BNP. Europace 8 (2006) 482-487
20. Devereux R.B., and Reichek N. Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation 55 (1977) 613-618
21. Kircher B.J., Himelman R.B., and Schiller N.B. Noninvasive estimation of right atrial pressure from the inspiratory collapse of the inferior vena cava. Am J Cardiol 66 (1990) 493-496
22. Tabata T., Grimm R.A., Asada J., et al. Determinants of LV diastolic function during atrial fibrillation: beat-to-beat analysis in acute dog experiments. Am J Physiol Heart Circ Physiol 286 (2004) H145-H152
23. Arteaga R.B., Hreybe H., Patel D., and Landolfo C. Derivation and validation of a diagnostic model for the evaluation of left ventricular filling pressures and diastolic function using mitral annulus tissue Doppler imaging. Am Heart J 155 (2008) 924-929
24. Hadano Y., Murata K., Tanaka N., et al. Ratio of early transmitral velocity to lateral mitral annular early diastolic velocity has the best correlation with wedge pressure following cardiac surgery. Circ J 71 (2007) 1274-1278
25. Soeki T., Fukuda N., Shinohara H., et al. Mitral inflow and mitral annular motion velocities in patients with mitral annular calcification: evaluation by pulsed Doppler echocardiography and pulsed Doppler tissue imaging. Eur J Echocardiogr 3 (2002) 128-134
26. Taylor J.A., Christenson R.H., Rao K., Jorge M., and Gottlieb S.S. B-type natriuretic peptide and N-terminal pro B-type natriuretic peptide are depressed in obesity despite higher left ventricular end diastolic pressures. Am Heart J 152 (2006) 1071-1076
27. Ceyhan C., Unal S., Yenisey C., Tekten T., and Ceyhan F.B. The role of N terminal pro-brain natriuretic peptide in the evaluation of left ventricular diastolic dysfunction: correlation with echocardiographic indexes in hypertensive patients. Int J Cardiovasc Imaging 24 (2008) 253-259
28. Elnoamany M.F., and Abdelhameed A.K. Mitral annular motion as a surrogate for left ventricular function: correlation with brain natriuretic peptide levels. Eur J Echocardiogr 7 (2006) 187-198
29. Lee S.H., Jung J.H., Choi S.H., et al. Determinants of brain natriuretic peptide levels in patients with lone atrial fibrillation. Circ J 70 (2006) 100-104
30. Oki T., Tabata T., Yamada H., et al. Evaluation of left atrial filling using systolic pulmonary venous flow velocity measurements in patients with atrial fibrillation. Clin Cardiol 21 (1998) 169-174